Translate NeuroProteXeon’s promising Xenon gas therapy into a commercial ventilator system that delivers precise, reliable treatment after cardiac arrest while supporting manufacturability and future commercialization.

Working alongside NPXe’s scientific team, Kaleidoscope conducted formative studies in the US and UK to inform bedside workflows, engineering, and user interface design. We specified components, unified global suppliers, and engineered the system for manufacturability from the outset.

Kaleidoscope unified multiple suppliers under a single design vision to deliver a manufacturable medical ventilator system that preserves the precision required for Xenon therapy while supporting commercialization and clinical use.